miltefosine has been researched along with Cancer of Spleen in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vase, MØ | 1 |
| Hellberg, YK | 1 |
| Larsen, CS | 1 |
| Petersen, E | 1 |
| Schaumburg, H | 1 |
| Bendix, K | 1 |
| Ravel, C | 1 |
| Bastien, P | 1 |
| Christensen, M | 1 |
| d'Amore, F | 1 |
1 other study available for miltefosine and Cancer of Spleen
| Article | Year |
|---|---|
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; HIV; HIV Infections; Humans; Immunophenotyping; K | 2012 |